A.S. Marriott

1.3k total citations
20 papers, 1.1k citations indexed

About

A.S. Marriott is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Physiology. According to data from OpenAlex, A.S. Marriott has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 6 papers in Psychiatry and Mental health and 5 papers in Physiology. Recurrent topics in A.S. Marriott's work include Neurotransmitter Receptor Influence on Behavior (6 papers), Migraine and Headache Studies (5 papers) and Neuroscience and Neuropharmacology Research (3 papers). A.S. Marriott is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (6 papers), Migraine and Headache Studies (5 papers) and Neuroscience and Neuropharmacology Research (3 papers). A.S. Marriott collaborates with scholars based in United Kingdom. A.S. Marriott's co-authors include Alma J. Gower, G.M. Drew, W. Feniuk, R.J.N. Tanner, P.P.A. Humphrey, Peter J. Elliott, Ann G. Hayes, P.S. Spencer, P.A. Fowler and Eppie Brown and has published in prestigious journals such as Brain, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

A.S. Marriott

20 papers receiving 992 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.S. Marriott United Kingdom 17 463 456 316 267 226 20 1.1k
S J Peroutka United States 15 712 1.5× 308 0.7× 342 1.1× 129 0.5× 463 2.0× 17 1.3k
M. Skingle United Kingdom 19 750 1.6× 320 0.7× 517 1.6× 147 0.6× 532 2.4× 29 1.3k
Elena del Olmo Spain 17 423 0.9× 174 0.4× 121 0.4× 88 0.3× 190 0.8× 20 834
R.S. Neuman Canada 24 1.1k 2.4× 150 0.3× 255 0.8× 46 0.2× 627 2.8× 36 1.5k
Geraint Price United Kingdom 6 1.1k 2.3× 91 0.2× 400 1.3× 42 0.2× 522 2.3× 9 1.4k
Walter Zieglgänsberger Germany 10 1.1k 2.4× 82 0.2× 254 0.8× 75 0.3× 281 1.2× 11 1.6k
Edmund G. Anderson United States 23 1.1k 2.3× 65 0.1× 1.0k 3.2× 106 0.4× 471 2.1× 35 1.7k
Hiroyuki Ikari Japan 18 517 1.1× 164 0.4× 193 0.6× 24 0.1× 313 1.4× 33 1.1k
C. Reyes‐Vázquez Mexico 19 432 0.9× 77 0.2× 274 0.9× 37 0.1× 186 0.8× 47 999
M.H. Millan Germany 21 1.1k 2.4× 284 0.6× 297 0.9× 16 0.1× 498 2.2× 45 1.4k

Countries citing papers authored by A.S. Marriott

Since Specialization
Citations

This map shows the geographic impact of A.S. Marriott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.S. Marriott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.S. Marriott more than expected).

Fields of papers citing papers by A.S. Marriott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.S. Marriott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.S. Marriott. The network helps show where A.S. Marriott may publish in the future.

Co-authorship network of co-authors of A.S. Marriott

This figure shows the co-authorship network connecting the top 25 collaborators of A.S. Marriott. A scholar is included among the top collaborators of A.S. Marriott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.S. Marriott. A.S. Marriott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riby, Leigh M., et al.. (2008). The effects of glucose ingestion and glucose regulation on memory performance in older adults with mild cognitive impairment. European Journal of Clinical Nutrition. 63(4). 566–571. 25 indexed citations
2.
Humphrey, P.P.A., et al.. (1991). Preclinical Studies on the Anti-Migraine Drug, Sumatriptan. European Neurology. 31(5). 282–290. 132 indexed citations
3.
Humphrey, P.P.A., W. Feniuk, A.S. Marriott, et al.. (1991). Self-Treatment of Acute Migraine with Subcutaneous Sumatriptan Using an Auto-Injector Device. European Neurology. 31(5). 323–331. 72 indexed citations
4.
Humphrey, P.P.A., W. Feniuk, A.S. Marriott, et al.. (1991). Evaluation of a Multiple-Dose Regimen of Oral Sumatriptan for the Acute Treatment of Migraine. European Neurology. 31(5). 306–313. 76 indexed citations
5.
Humphrey, P.P.A., W. Feniuk, A.S. Marriott, et al.. (1991). A Placebo-Controlled Study of Intranasal Sumatriptan for the Acute Treatment of Migraine. European Neurology. 31(5). 332–338. 51 indexed citations
6.
Humphrey, P.P.A., W. Feniuk, A.S. Marriott, et al.. (1991). Sumatriptan An Oral Dose-Defining Study. European Neurology. 31(5). 300–305. 98 indexed citations
7.
Elliott, Peter J., et al.. (1990). Neuroleptic-induced catalepsy as a model of Parkinson's disease II. Effect of glutamate antagonists. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 2(2). 91–100. 55 indexed citations
8.
Elliott, Peter J., et al.. (1990). Effects of classical and novel agents in a MPTP-induced reversible model of Parkinson's disease. Psychopharmacology. 102(3). 295–300. 53 indexed citations
9.
Elliott, Peter J., et al.. (1990). Neuroleptic-induced catalepsy as a model of Parkinson's disease I. Effect of dopaminergic agents. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 2(2). 79–89. 27 indexed citations
10.
Marriott, A.S., et al.. (1988). D2 dopamine receptors in rat striatum are homogeneous as revealed by ligand-binding studies. Biochemical Pharmacology. 37(22). 4335–4339. 7 indexed citations
11.
Allen, J.M., A.J. Cross, J.C. Yeats, et al.. (1986). NEUROPEPTIDES AND DOPAMINE IN THE MARMOSET. Brain. 109(1). 143–157. 41 indexed citations
12.
Marriott, A.S., et al.. (1985). Failure of SKF 38393‐A to relieve parkinsonian symptoms induced by 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine in the marmoset. British Journal of Pharmacology. 85(2). 320–322. 56 indexed citations
13.
Gower, Alma J. & A.S. Marriott. (1982). PHARMACOLOGICAL EVIDENCE FOR THE SUBCLASSIFICATION OF CENTRAL DOPAMINE RECEPTORS IN THE RAT. British Journal of Pharmacology. 77(1). 185–194. 49 indexed citations
14.
Drew, G.M., Alma J. Gower, & A.S. Marriott. (1979). α2‐ADRENOCEPTORS MEDIATE CLONIDINE‐INDUCED SEDATION IN THE RAT. British Journal of Pharmacology. 67(1). 133–141. 227 indexed citations
15.
Drew, G.M., Alma J. Gower, & A.S. Marriott. (1977). Pharmacological characterization of alpha-adrenoceptors which mediate clonidine-induced sedation [proceedings].. PubMed. 61(3). 468P–468P. 16 indexed citations
16.
Marriott, A.S., M. Skingle, & M.B. Tyers. (1975). Proceedings: Evaluation of narcotic and narcotic antagonist analgesic drugs in the dog dental pulp stimulation test.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 55(2). 314P–314P. 1 indexed citations
17.
Marriott, A.S., et al.. (1972). An analysis of drug effects in mice exposed to a simple novel environment. Psychopharmacology. 24(3). 397–406. 38 indexed citations
18.
Marriott, A.S., et al.. (1969). The effects of drugs on the hyper-reactivity of rats with bilateral anterior hypothalamic lesions.. PubMed. 37(2). 507P–508P. 3 indexed citations
19.
Marriott, A.S.. (1968). The effects of amphetamine, caffeine and methylphenidate on the locomotor activity of rats in an unfamiliar environment. International Journal of Neuropharmacology. 7(6). 487–491. 30 indexed citations
20.
Marriott, A.S. & P.S. Spencer. (1965). EFFECTS OF CENTRALLY ACTING DRUGS ON EXPLORATORY BEHAVIOUR IN RATS. British Journal of Pharmacology and Chemotherapy. 25(2). 432–441. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S J Peroutka Breakdown of academic impact, for papers by M. Skingle Breakdown of academic impact, for papers by Elena del Olmo Breakdown of academic impact, for papers by R.S. Neuman Breakdown of academic impact, for papers by Geraint Price Breakdown of academic impact, for papers by Walter Zieglgänsberger Breakdown of academic impact, for papers by Edmund G. Anderson Breakdown of academic impact, for papers by Hiroyuki Ikari Breakdown of academic impact, for papers by C. Reyes‐Vázquez Breakdown of academic impact, for papers by M.H. Millan
Rankless by CCL
2026